The Distinguished Collaboration Series (DCS) is a new lecture format from a team of distinguished internal speakers. The lectures focus on different aspects of the same scientific/clinical problem and explores the interrelationships between basic cancer research and clinical medicine.
Distinguished Collaboration Series 2023-24
Drs. Antonio Iavarone, (Lead), Anna Lasorella, and Defne Bayik
“The Molecular Evolution of Glioblastoma Under Therapy”
Distinguished Collaboration Series 2022-23
Drs. Scott Welford (Lead), Stephen Lee, and Jaime Merchan
“The Cellular Response to Hypoxia”
Drs. Nipun Merchant (Lead), Jashodeep Datta, and Peter Hosein
"Mission Impossible? Discovering a Novel Strategy to Overcome Immunotherapy Resistance in Pancreatic Cancer"
Distinguished Collaboration Series 2021-22
Drs. J. William Harbour (Lead), Stefan Kurtenbach, and Zelia M. Correa
"Clinical, Translational and Basic Research Advances in Uveal Melanoma"
Drs. Stephen Lee and Jonathan Schatz
"Transcription-Independent Survival: How Tumors Reprogram Translation to Survive Stress and Resist Therapy"
Drs. Diane C. Lim (Lead), Medhi Wangpaichitr, Gregory Holt, and Cheng-Bang Chen
"A Translational Approach to Lung Cancer"
Distinguished Collaboration Series 2020-21
Drs. Erin Kobetz (Lead), Sylvia Daunert and Sapna Deo
"From HPV to COVID: Interdisciplinary Collaboration to Advance Health Equity"
Drs. Maria Figueroa (Lead), Justin Watts and Luisa Cimmino
"IDH1/2 and TET2 Mutations in Myeloid Malignancies: Metabolism Meets Epigenetics"
Drs. Nagi Ayad (Lead), Macarena de la Fuente and Michael Ivan
“Personalized Approaches for IDH Mutant Glioma”
Distinguished Collaboration Series 2019-20
Drs. Michael Antoni (Lead) and Bonnie Blomberg
"Examining the Effects of Stress Processes and Stress Management on Biobehavioral Processes and Health Outcomes in Breast cancer"
Dr. Joyce Slingerland (Lead) and Lluis Morey
"New Insights on the Estrogen Receptor Functions in Breast Cancer"
Distinguished Collaboration Series 2018-19
Drs. Andrew Maudsley (Lead), Michael Ivan and Antonio Omuro
“Advances in Brain Tumor Imaging”
Drs. Priyamvada Rai (Lead), Dao Nguyen and Marcus Cooke
“Oxidation in the nucleotide pool as a novel therapeutic target in RAS-driven lung cancer”
Drs. Joseph Rosenblatt (Lead) and Sundaram Ramakrishnan
“Targeting Tumor Vasculogenic Mimicry and Invasion; Endostatin Revisited”
Distinguished Collaboration Series 2017-18
Drs. Marc Lippman (Lead) and Barry Hudson
“Targeting RAGE as a novel therapy for breast cancer”
Drs. Paolo Serafini (Lead), Donald Weed, and Natasa Strbo
“Disrupting tumor immunosuppression and priming immune response in head and neck squamous cell carcinoma”
Drs. Maria Abreu (Lead), Joyce Slingerland, and Daniel Sussman
“Can we target innate immune pathways in the prevention or treatment of colorectal cancer?”
Distinguished Collaboration Series 2016-17
Drs. Jonathan Trent (Lead), David Robbins, and Josiane Eid
“WNT Pathway and its Inhibition in Sarcoma”
Drs. Brian Slomovitz (Lead), Sophia George, and Rachel Silva-Smith
“Advances in the management of hereditary ovarian cancer: homologous repair deficiency mutation and their implications on prevention and treatment”
Drs. Allan Pollack (Lead), Radka Stoyanova, and Sanoj Punnen
“Quantitative multiparametric MRI as an adjunct to prostate cancer precision diagnosis and management”
Drs. Ronan Swords (Lead), Ramin Shiekhattar, and Arthur Zelent
“Targeting the Lysine Demethylase LSD1 in Acute Myeloid Leukemia”
Drs. Nicolas Acquavella, and Jeong Hee Cho
“Melanoma"